Numelvi 21.6mg (L) - 90 Tablets
MSD |
219138

Numelvi 21.6mg (L) - 90 Tablets

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description

Numelvi (atinvicitinib) is the first and only second-generation JAK1 inhibitor for dogs indicated for the symptomatic treatment of pruritus, inflammation and clinical signs associated with allergic dermatitis, including atopic dermatitis . It is suitable for dogs and puppies from 6 months of age and 2 kg body weight.

Active: Atinvicitinib (21.6mg)

Pack Size: 90 Tablets

Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription
Species:
Dog
Ingredients:
ATINVICITINIB 21.6 MG TABS